Proposed Dividend: CHF 3.50 per share, a 6% increase. Novartis AG (NYSE:NVS) reported a strong financial performance for 2024, with a 16% increase in Q4 sales and a 29% rise in core operating ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Schaffert said: "Becoming CEO of Novartis Oncology is a great honour and I am humbled to be given the opportunity to lead one of the top-tier oncology businesses in the world.

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company ... pharmaceuticals after acquiring Germany's Hexal AG and US-based Eon Labs. The same year, Novartis ...

PORTLAND, IL, UNITED STATES, February 3, 2025 /EINPresswire / -- According to the recent report released by Allied market Research, the global transdermal drug delivery systems market size is ...